课题基金 / 基金详情

Hypercapnia as Therapy for Neonatal Pulmonary Hypertension

Hypercapnia as Therapy for Neonatal Pulmonary Hypertension
高碳酸血症治疗新生儿肺动脉高压
批准号：
172491
负责人：
Jankov Robert P
金额：
$42.24万
依托单位：
Sunnybrook Research Institute (Toronto, Ontario)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2008
资助国家：
加拿大
项目状态：
已结题
起止时间：
2008-09-01 至 2013-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=172491&lang=en
关键词：
Carbon Dioxide Hypercapnia Hypoxia Inflammation Pulmonary Hypertension

项目摘要

项目成果

Jankov Robert P的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Pulmonary hypertension (high blood pressure in the lung) is a complication that requires medical treatment in about 1 in 500 newborn infants and commonly leads to death in the most severe cases. This disease is common in the newborn period because of two
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ceramides as a therapeutic target in experimental bronchopulmonary dysplasia
Elucidating a role for Rho-kinase-thrombospondin signaling in experimental and human bronchopulmonary dysplasia: Novel targets for prevention and treatment of chronic lung disease in premature newborns.
Sex differences in arginine function in experimental and human bronchopulmonary dysplasia
Preclinical Assessment of Rho-kinase Inhibitors for Chronic Pulmonary Hypertension
海外基金